Molecular and immunological associations of elevated serum lactate dehydrogenase in metastatic melanoma patients: A fresh look at an old biomarker-Reference-Cited by-同舟云学术

Molecular and immunological associations of elevated serum lactate dehydrogenase in metastatic melanoma patients: A fresh look at an old biomarker

Published:2020-10-05 Issue:22 Volume:9 Page:8650-8661
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Fischer Grant M.¹²^ORCID,Carapeto Fernando C. L.¹,Joon Aron Y.³,Haydu Lauren E.⁴,Chen Huiqin³,Wang Fuchenchu³,Van Arnam John S.¹,McQuade Jennifer L.²,Wani Khalida¹,Kirkwood John M.⁵,Thompson John F.⁶⁷⁸,Tetzlaff Michael T.¹⁹,Lazar Alexander J.¹⁹¹⁰^ORCID,Tawbi Hussein A.²,Gershenwald Jeffrey E.⁴,Scolyer Richard A.⁶⁷⁸,Long Georgina V.⁶⁷¹¹,Davies Michael A.¹²¹²^ORCID

Affiliation:

1. Departments of Translational Molecular Pathology The University of Texas MD Anderson Cancer Center Houston TX USA

2. Melanoma Medical Oncology The University of Texas MD Anderson Cancer Center Houston TX USA

3. Biostatistics The University of Texas MD Anderson Cancer Center Houston TX USA

4. Surgical Oncology The University of Texas MD Anderson Cancer Center Houston TX USA

5. University of Pittsburgh Medical Center Pittsburgh PA USA

6. Melanoma Institute of AustraliaThe University of SydneyNorth Sydney NSW Australia

7. The University of Sydney Sydney NSW Australia

8. Royal Prince Alfred HospitalNSW Health Pathology Sydney NSW Australia

9. Pathology/Lab Medicine The University of Texas MD Anderson Cancer Center Houston TX USA

10. Genomic Medicine The University of Texas MD Anderson Cancer Center Houston TX USA

11. Royal North Shore Hospital Sydney NSW Australia

12. Systems Biology The University of Texas MD Anderson Cancer Center Houston TX USA

Funder

AIM at Melanoma

Cancer Prevention and Research Institute of Texas

Dr. Miriam and Sheldon G. Adelson Medical Research Foundation

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3474

Reference37 articles.

1. Circulating Serologic and Molecular Biomarkers in Malignant Melanoma

2. Methods for the separation of lactate dehydrogenases and clinical significance of the enzyme

3. Prognostic factors for survival of patients treated systemically for disseminated melanoma.

4. Prognostic factors in patients with metastatic malignant melanoma;Sirott MN;A multivariate analysis Cancer,1993

5. S100-Beta, Melanoma-Inhibiting Activity, and Lactate Dehydrogenase Discriminate Progressive From Nonprogressive American Joint Committee on Cancer Stage IV Melanoma

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined Anti-PD-1 and Anti-CTLA-4 Treatment in Stage IV Melanoma Patients: A Bicentric Analysis of Real-World Data and a Modern Treatment Scenario Proving Lactate Dehydrogenase’s Usefulness;Diagnostics;2024-03-20

2. The Use of Gene Expression Profiling and Biomarkers in Melanoma Diagnosis and Predicting Recurrence: Implications for Surveillance and Treatment;Cancers;2024-01-30

3. Correlation of Baseline Tumor Burden with Clinical Outcome in Melanoma Patients Treated with Ipilimumab;Oncology;2023-08-14

4. Changes in the level of zinc and copper and some biochemical parameters in patients with chronic kidney failure;Biomedical and Biotechnology Research Journal (BBRJ);2023

5. An analysis of lactate dehydrogenase (LDH) levels in advanced stage IV melanoma of the skin: prognostic capabilities and demographic variability;Archives of Dermatological Research;2022-11-01